Global Animal Model Market - Global Forecast 2027

Market Overview –

The Global Animal models market are expected to grow at a CAGR of 6.2 percent over the next five years in the global animal model market. The pharmaceutical industry’s explosive growth in developing drugs, antibodies, and medicines against new and re-emerging diseases, as well as the growing use of animal models in research labs for prognostic and diagnostic purposes, are expected to be major factors driving revenue growth in the market during the forecast period. Another factor that is predicted to drive the market’s revenue growth is an increase in the demand for animal models for educational purposes by academic and biotechnological institutions.

Because of their similarity to humans in immunology and pathophysiology, animal models are used in experiments and research. Studies on diseases, drug discovery and development and even cell and histological research all make use of them. 100 million mice and rats, as well as 1 million other animals, were kept in captivity in the United States for research and laboratory experiments in 2019. The use of human models for research is fraught with controversy due to concerns about the potential for harm to human life.

As a result, animal models that closely mimic human systems are preferred as an alternative. These models are frequently used by pharmaceutical companies, academic and biotechnological institutions, and other organisations. Pharmaceutical companies rely on animal models when developing drugs for human diseases because they can mimic the human immune response when infected with the disease in question. Anatomical dissection and microscopic examination of histological sections are routinely performed on mice, rats, and frogs in academic institutions.

COVID 19 Analysis –

One of the major challenges that the animal model market is currently dealing with is covering up the losses and not leaving the coronavirus’s impact in the past. Even countries with well-established healthcare systems and infrastructure have been affected by the pandemic’s global reach. In the animal model market, the supply chain has been severely disrupted by the pandemic, which has put a strain on production and manufacturing units to keep up with demand. As a result of the lockdown imposed by global governments during the forecast period of 2021-2028, the services and production sector has been unable to meet the expected quality standards for the animal model market.

Governments around the world have been increasing their support for rolling schemes and regulations, as well as funding global research and development initiatives, during the current forecast period Consolidation of the regional and global markets will be aided by strategic alliances, acquisitions, mergers, and joint venture agreements. The global target audience is likely to benefit from new products that are developed and launched by the market players.

Market Dynamics –

The pharmaceutical industry has seen a dramatic increase in drug discovery and development over the past decade, mainly due to the global spread of diseases that were previously restricted to a specific geographic area and the emergence of new diseases, such as coronavirus. Researchers around the world have been compelled to produce treatment methods at a faster rate due to the rapid spread of infections to pandemic levels. Despite being more precise, human models cannot be used in drug development experiments because of the danger they pose to the subjects’ lives.

An important factor in increasing adoption in clinical trials, and thus driving market revenue growth, is that animal models ensure minimal risk to human lives while producing. The use of animal models in basic and applied research is another factor that is expected to drive revenue growth. Genetically modified models are increasingly being used by researchers in basic research to better understand metabolic pathways, life processes, and mechanisms, and to also take an experimental approach to scientific problems and find solutions using “disease models” (in applied research).

Academic institutions also use models to demonstrate anatomical dissections and histological sections of certain organs for microscopic study in their laboratories. Between 2022 and 2030, the demand for these models is expected to grow, which will support the market’s revenue growth.

Market Scope and Market Size –

Depending on the type, species, and form, the animal feed market can be broken down further. Segment growth helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

In terms of type, the animal feed market is broken down into acidifying agents (such as vinegar), probiotics, enzymes, antioxidants, antibiotics, amino acids, vitamins, and minerals.
In the animal feed market, poultry, ruminants, aqua and swine are just a few of the subcategories.
Pellets, crumbles, mash, and other forms of animal feed are subdivided into categories.

Customization Available –

ZMR is a pioneer in cutting-edge formative research. We take great pride in providing our customers with data and analysis that are tailored to their specific needs and objectives. Price trend analysis of target brands can be customised to include price data for additional countries, clinical trial results, literature review, refurbished market and product base analysis of the refurbished market (ask for the country list). The market analysis of target competitors can be analysed from a technology-based perspective to a market portfolio strategy.. In the format and data style you desire, we can add as many competitors as needed to your list. It is also possible for us to deliver raw Excel files with pivot tables (Fact book) and assist with the creation of presentations from the data sets in the report.

Competitive Landscape –

The competitive landscape of the animal feed market provides information by competitor. Financials and revenue, market potential, investment in R&D and new market initiatives as well as a global presence, production facilities, production capacities as well as a range of strengths and weaknesses of the company are among the details included in the report. Only data points relating to the animal feed market are included in this list of companies’ data.

Key Players –

Charles River Laboratories International, Inc.
Horizon Discovery Group plc.
The Jackson Laboratory
Taconic Biosciences, Inc.
Genoway SA
Eurofins Scientific SE
Crown Bioscience, Inc.
Envigo CRS SA
Transposagen Biopharmaceuticals, Inc.

By Type –

Rats
Mice
Guinea Pig
Rabbits
Monkeys
Dogs
Pigs
Cats

By Applications –

Academic & Research Instututions
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizaitons

By Regions –

North America
Latin America
Europe
South Korea
APAC
Middle East